Cannabinoids

    2/25/2009 2:02:45 PM Tocris Bioscience (www.tocris.com) is pleased to announce the launch of Tocrifluor T1117. Co developed by Tocris and the University of Glasgow, Tocrifluor T1117 is the CB1 antagonist AM 251 labelled with a rhodamine derivative, and is the first fluorescent cannabinoid ligand commercially available. New research published by Daly et al […]

by

Cannabinoid Receptor Ligands Part 1 Roger G Pertwee School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen Roger Pertwee is currently Professor of Neuropharmacology at the University of Aberdeen and Director of Pharmacology for GW Pharmaceuticals. His research focuses on thepharmacology of cannabis and its constituents and of cannabinoid receptors and […]

by

aka Toxicology Conundrum 043 A 29 year-old male presents to the ED with a chief complaint of incessant nausea and vomiting for the past 24 hours, with associated abdominal cramping. You pick up his chart and notice that this is his tenth presentation to ED in the last 2 years with similar complaints each time. Previous […]

by

Patricia H. Reggio As research has progressed, the cannabinoid CB 1 and CB 2 receptors have expanded significantly in importance within the neuroscience mainstream. In The Cannabinoid Receptors, leading experts introduce newcomers to the cannabinoid field with chapters covering cannabinoid ligand synthesis and structure activity relationships, the molecular pharmacology of the cannabinoid receptors and the […]

by

Posted on August 16, 2011 Facebook Cash Profits Review The chemical aspects of Medical Marijuana, referred to help as cannabinoids, play a major role with the realm from medicine called CAM (Complementary and Alternative Medicine). Healthcare Marijuana, also know when Medical Cannabis, has been put to use in lots of different medicinal uses for some […]

by

Hello Everyone, I am new here and would like to say hello to everyone and also commend everyone on taking steps towards stopping addiction/ staying quit. I have lived a life of addiction. I am an addict and and alcoholic. I have abstained from alcohol for a five years, only because of my marijuana addiction. […]

by

Researchers find CB1 suppresses tumors, a new potential path for treatment, prevention New preclinical research shows that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer, scientists report in the Aug. 1 edition of the journal Cancer Research. CB1 is well-established for relieving pain and nausea, elevating mood and stimulating appetite […]

by

diabetesjournals.org OBJECTIVE The TrialNet Study Group evaluated rituximab, a B-cell–depleting monoclonal antibody, for its effect in new-onset patients with type 1A diabetes. Rituximab decreased the loss of C-peptide over the first year of follow-up and markedly depleted B-lymphocytes for 6 months after administration. This article analyzes the specific effect of rituximab on multiple islet autoantibodies. […]

by

Herbal incense blends which partly consist of synthetic cannabinoids are bountiful at the moment. Synthetic cannabinoids may provide a user with a high similar to that provided to users by tetrahydrocannabinol, or THC, the cannabinoid found in cannabis. In fact, the high provided by some of these k2 smoke herbal blends may far exceed the […]

by

Title: Variation in the human Cannabinoid Receptor (CNR1) gene modulates gaze duration for happy facesAuthors: Chakrabarti, BhismadevBaron-Cohen, SimonIssue Date: 29-Jun-2011Abstract: Abstract Background From an early age, humans look longer at preferred stimuli and also typically look longer at facial expressions of emotion, particularly happy faces. Atypical gaze patterns towards social stimuli are common in autism spectrum conditions (ASC). However, […]

by